Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HD domain-containing protein 3 (HDDC3), also known as MESH1 (Metazoan SpoT homolog 1), is a cytosolic enzyme homologous to the bacterial SpoT hydrolase, with known activity as a guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase ((ppGpp)ase)[2][3][8]. It contributes to the regulation of the cellular response to nutrient starvation and plays a key role in regulating NADPH levels and dNTP pool synthesis in mammalian cells[1][2][3][8]. In humans, depletion or inhibition of HDDC3/MESH1 leads to proliferation arrest in cancer cells, depletion of dNTPs, repression of key proliferative transcriptional regulators (like TAZ), and protection against ferroptosis, indicating its potential as a therapeutic target in oncology[1][2]. HDDC3 is associated with chromatin modifications and cellular stress response pathways, and its higher expression is linked to cancer progression and poor clinical outcomes[1][3]. There is no known approved drug targeting HDDC3, but its central role in proliferation and metabolic adaptation identifies it as a candidate for novel therapeutic interventions[1][2].
Enzymatic hydrolysis of (p)ppGpp and regulation of metabolic stress pathways[3][8]\nRegulation of cell proliferation via epigenetic repression of TAZ expression[1]\nRegulation of NADPH levels and ferroptosis susceptibility[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HD domain-containing protein 3 (HDDC3).